FIS
FCPM III Services Portfolio holdings
AUM
$763M
1-Year Est. Return
23.18%
This Fund
S&P 500
1 Year Est. Return
+23.18%
AUM
$500M
AUM Growth
+$131M
(+36%)
Holding
9
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$3.47B
| $262M | 52.36% |
9,212,384
-1,419,729
|
|
||
2
Dyne Therapeutics
DYN
$2.5B
| $69.1M | 13.81% |
5,462,846
|
|
||
3
enGene Holdings
ENGN
$583M
| $65.8M | 13.15% |
9,632,561
|
|
||
|
ATXS
4
DELISTED
Astria Therapeutics
ATXS
| $29.9M | 5.98% |
4,107,537
|
|
||
|
BCYC
5
Bicycle Therapeutics
BCYC
$371M
| $26.7M | 5.34% |
3,452,330
|
|
||
6
Vor Biopharma
VOR
$605M
| $18.5M | 3.7% |
+379,640
|
|
||
7
Replimune Group
REPL
$581M
| $17.4M | 3.48% |
4,158,368
+248,672
|
|
||
8
RAPT Therapeutics
RAPT
| $8.88M | 1.77% |
344,237
-95,939
|
|
||
|
9
enGene Holdings Warrants
ENGNW
$33.8M
| $2.07M | 0.41% |
2,878,148
|
|